Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Prospective Study: the Impact of Sleep Disturbances on Immunotherapy in Patients With Lung Cancer
Sponsor: Shanghai Zhongshan Hospital
Summary
In recent years, immunotherapy has made significant progress in the treatment of lung cancer, especially immune checkpoint inhibitors (such as PD-1/PD-L1 antibodies) against non-small cell lung cancer (NSCLC). However, there are significant individual differences in patient response to treatment. Studies have shown that sleep disorders may affect the function of the immune system, thereby affecting tumor progression and treatment response. Therefore, the aim of this study was to evaluate the impact of sleep disturbances on lung cancer patients receiving immunotherapy.
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
OBSERVATIONAL
Enrollment
350
Start Date
2025-06-01
Completion Date
2028-12-30
Last Updated
2025-05-01
Healthy Volunteers
No
Interventions
PSQI
Prospective observational cohort study: Cohort o: Stratified according to baseline sleep disorder severity (PSQI score ≥7 vs. \<7).
PQSI
PQSI-Sleep quality assessment scale